Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719205 | PMC |
| http://dx.doi.org/10.34172/ijhpm.2020.109 | DOI Listing |
Publication Analysis
Top Keywords
underperformance reverse-transcriptase
4
reverse-transcriptase polymerase
4
polymerase chain
4
chain reaction
4
reaction japan
4
japan potential
4
potential implications
4
implications diamond
4
diamond princess
4
princess cruise
4
Similar Publications
Underperformance of Reverse-Transcriptase Polymerase Chain Reaction in Japan and Potential Implications From Diamond Princess Cruise Ship and Other Countries During the Ongoing COVID-19 Pandemic.
Int J Health Policy Manag
November 2020
School of Public Health, Fudan University, Shanghai, China.
Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review.
AIDS Res Treat
September 2017
Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA.
Background: Darunavir is a second-generation protease-inhibitor used with ritonavir (DRV/r) and two nucleoside reverse-transcriptase inhibitors as an option in first-line antiretroviral treatment (ART).
Methods: We systematically reviewed randomized controlled trials (RCTs) of DRV/r versus other regimens in patients initiating ART. We searched five bibliographic databases and other key resources.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!